| Page 7233 | Cafepharma

You are here

Johnson & Johnson's Reputation Begins to Slide

Johnson & Johnson's Reputation Begins to Slide

Seeking Alpha

ZymoGenetics reports positive skin cancer drug results

ZymoGenetics reports positive skin cancer drug results

Bizjournals.com

U.S. Can Continue Stem-Cell Funding, Court Says

U.S. Can Continue Stem-Cell Funding, Court Says

Bloomberg

Big gamble that built a big biotech

Big gamble that built a big biotech

FT.com

Gaucher disease

Genzyme Chief Prepared to Leave to Ease Deal

Genzyme Chief Prepared to Leave to Ease Deal

NY Times, NY

J&J's Quality Control Draws Scrutiny

J&J's Quality Control Draws Scrutiny

WSJ Online

quality control

Sanofi-Aventis Said to Weigh Raising $69-a-Share Offer to Buy Genzyme

Sanofi-Aventis Said to Weigh Raising $69-a-Share Offer to Buy Genzyme

Bloomberg

Feds To Fine Pharma For Failing To Report Prices

Feds To Fine Pharma For Failing To Report Prices

Pharmalot

J&J CEO to address recalls; Tylenol brand dips

J&J CEO to address recalls; Tylenol brand dips

Yahoo/AP

Study: Give more statins, save more money

Study: Give more statins, save more money

Fierce Pharma

Pages